251 related articles for article (PubMed ID: 25315799)
21. Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia: An Analysis of SEER-Medicare Data From 1995 to 2007.
Lin PJ; Winn AN; Parsons SK; Neumann PJ; Weiss ES; Cohen JT
Med Care; 2016 Apr; 54(4):380-5. PubMed ID: 26759984
[TBL] [Abstract][Full Text] [Related]
22. Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013.
Beinortas T; Tavorienė I; Žvirblis T; Gerbutavičius R; Jurgutis M; Griškevičius L
BMC Cancer; 2016 Mar; 16():198. PubMed ID: 26956037
[TBL] [Abstract][Full Text] [Related]
23. The roles of age and sex in the prognosis of chronic leukaemias. A study of 373 cases.
Jaksić B; Vitale B; Hauptmann E; Planinc-Peraica A; Ostojic S; Kusec R
Br J Cancer; 1991 Aug; 64(2):345-8. PubMed ID: 1892761
[TBL] [Abstract][Full Text] [Related]
24. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
Pulte D; Gondos A; Brenner H
Cancer; 2009 Nov; 115(21):4973-9. PubMed ID: 19705347
[TBL] [Abstract][Full Text] [Related]
25. A morphological pattern of 234 cases of leukemias.
Hassan K; Ikram N; Shah SH
J Pak Med Assoc; 1994 Jun; 44(6):145-8. PubMed ID: 8089909
[TBL] [Abstract][Full Text] [Related]
26. Chronic myeloid leukemia in the Netherlands: a population-based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012.
Thielen N; Visser O; Ossenkoppele G; Janssen J
Eur J Haematol; 2016 Aug; 97(2):145-54. PubMed ID: 26519944
[TBL] [Abstract][Full Text] [Related]
27. The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review.
Crişan AM; BădeliŢă SN; Jardan C; Vasilache ED; Dobrea CM; Gheorghe A; Tălmaci R; Arion CV; Bardaş A; Găman AM; Coriu D
Rom J Morphol Embryol; 2015; 56(3):1145-51. PubMed ID: 26662151
[TBL] [Abstract][Full Text] [Related]
28. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century.
Brenner H; Gondos A; Pulte D
Blood; 2008 May; 111(10):4916-21. PubMed ID: 18309034
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990-2018.
Howlader N; Sharon E; Bhattacharya M; Ehrlich LA; Richardson NC; Gormley NJ; de Claro RA; Wood AE; Mariotto AB; Cronin KA
Cancer Epidemiol Biomarkers Prev; 2023 Jun; 32(6):744-747. PubMed ID: 37012203
[TBL] [Abstract][Full Text] [Related]
30. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
[TBL] [Abstract][Full Text] [Related]
31. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
Cohen MH; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
[TBL] [Abstract][Full Text] [Related]
32. [Descriptive epidemiology of myeloid leukemia].
Matsuo K; Ito H
Nihon Rinsho; 2009 Oct; 67(10):1847-51. PubMed ID: 19860178
[TBL] [Abstract][Full Text] [Related]
33. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
34. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
Polednak AP
J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
[TBL] [Abstract][Full Text] [Related]
35. Upper aerodigestive tract cancer in patients with chronic lymphocytic leukemia: incidence, stage, and outcome.
Pagedar NA; Halfdanarson TR; Karnell LH; Hoffman HT; Funk GF
Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1171-5. PubMed ID: 23247237
[TBL] [Abstract][Full Text] [Related]
36. Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database 1988-2008.
Goggins WB; Lo FF
Cancer Causes Control; 2012 May; 23(5):737-43. PubMed ID: 22450738
[TBL] [Abstract][Full Text] [Related]
37. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
[TBL] [Abstract][Full Text] [Related]
38. Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985-2017).
Alrawashdh N; Sweasy J; Erstad B; McBride A; Persky DO; Abraham I
Ann Hematol; 2021 Oct; 100(10):2501-2512. PubMed ID: 34279676
[TBL] [Abstract][Full Text] [Related]
39. [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia].
Hattori H; Kuwayama M; Kotake T; Karasuno T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):333-6. PubMed ID: 21368508
[TBL] [Abstract][Full Text] [Related]
40. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
